Skip to main content

King’s People

Professor Lars Holmberg

Emeritus staff

Emeritus Professor

Contact details

Biography

Lars Holmberg is Professor Emeritus in Cancer Epidemiology at School of Cancer and Pharmaceutical Sciences, King’s College London and at Medical Faculty, University of Uppsala Sweden. Prof Holmberg was recruited to KCL in 2007 to head up an epidemiology group. In 2011, Prof Holmberg also took up the leadership for a Regional Cancer Center in Uppsala, Sweden jointly with his appointment at KCL. Prof Holmberg holds after his retirement in 2016 grants for breast-, prostate- and urinary bladder cancer research and mentors younger colleagues in cancer epidemiology. Prof Holmberg has published more than 350 original articles and 80 reviews and commentaries.

Latest publications

Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)
Aljabery, F., Liedberg, F., HÃ¤ggstrÃ¶m, C., StrÃ¶ck, V., Hosseini, A., GÃ¥rdmark, T., Sherif, A., JerlstrÃ¶m, T., MalmstrÃ¶m, P. U., Hagberg, O. & Holmberg, L., 1 Nov 2020, In : BJU International. 126, 5, p. 625-632 8 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1111/bju.15198
A mediation analysis to explain socio-economic differences in bladder cancer survival
Russell, B., Hemelrijck, M. V., GÃ¥rdmark, T., Holmberg, L., Kumar, P., Bellavia, A. & HÃ¤ggstrÃ¶m, C., 1 Oct 2020, In : Cancer Medicine. 9, 20, p. 7477-7487 11 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1002/cam4.3418
Changes in lifestyle among prostate cancer survivors: A nationwide population-based study
Bergengren, O., Enblad, A. P., Garmo, H., Bratt, O., Holmberg, L., Johansson, E. & Bill-Axelson, A., 1 Oct 2020, In : Psycho-Oncology. 29, 10, p. 1713-1719 7 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1002/pon.5513
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
Beckmann, K., Garmo, H., Lindahl, B., Holmberg, L., Stattin, P., Adolfsson, J., Cruickshank, J. K. & Van Hemelrijck, M., 1 Sep 2020, In : PROSTATE CANCER AND PROSTATIC DISEASES. 23, 3, p. 527-533 7 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1038/s41391-020-0220-8
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study
Valachis, A., Garmo, H., Fredriksson, I., Sund, M., Lagerqvist, B. & Holmberg, L., 1 May 2020, In : Breast Journal. 26, 5, p. 981-987 7 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1111/tbj.13759
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the 'ATRESS' phenomenon
Jurrius, P., Green, T., Garmo, H., Young, M., Cariati, M., Gillett, C., Mera, A., Harries, M., Grigoriadis, A., Pinder, S., Holmberg, L. & Purushotham, A., 1 Apr 2020, In : Breast. 50, p. 39-48 10 p. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1016/j.breast.2020.01.006
Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: A nationwide cohort study
Plym, A., Clements, M., Voss, M., Holmberg, L., Stattin, P. & Lambe, M., 9 Mar 2020, In : BMJ Open. 10, 3, e032914. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1136/bmjopen-2019-032914
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 28 Feb 2020, In : Frontiers in oncology. 10, p. 263 263. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.3389/fonc.2020.00263
Serum immunoglobulin G is associated with decreased risk of pancreatic cancer in the Swedish AMORIS study
Sollie, S., Santaolalla, A., Michaud, D. S., Sarker, D., Karagiannis, S. N., Josephs, D. H., Hammar, N., Walldius, G., Garmo, H., Holmberg, L., Jungner, I. & Van Hemelrijck, M., 14 Feb 2020, (Accepted/In press) In : Frontiers in oncology. Research output: Contribution to journal - Article
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: Results from a large population-based cohort
Wennstig, A. K., Wadsten, C., Garmo, H., Fredriksson, I., Blomqvist, C., Holmberg, L., Nilsson, G. & Sund, M., 22 Jan 2020, In : Breast Cancer Research. 22, 1, 10. Research output: Contribution to journal - Article. DOIs: https://doi.org/10.1186/s13058-020-1249-2

View all publications